Frontotemporal dementia in elderly individuals.

OBJECTIVE To determine whether cases of frontotemporal lobar degeneration (FTLD) do exist in elderly individuals and have clinical and neuropathological features distinct from those with presenile onset. DESIGN Retrospective matched cohort study. SETTING Regional Neuroscience Centre, North East England. PATIENTS We compared clinicopathological features of 11 cases of FTLD in elderly individuals with 19 cases of presenile-onset FTLD. RESULTS Retrospective case note analysis showed that most elderly patients with FTLD had behavioral features consistent with orbitofrontal and basofrontal involvement, similar to presenile-onset FTLD, though symptomatic memory loss was present in 91% (10 of 11) of elderly patients with FTLD compared with only 36% (7 of 19) of patients with presenile-onset FTLD. Neuropathologically, the group of elderly patients with FTLD comprised 7 with FTLD–TDP-43, 1 with ubiquitin-positive FTLD, 2 with FTLD-tau/Pick disease, and 1 with FTLD-tau/neurofibrillary tangle–predominant dementia with TDP-43, a composition similar to presenile-onset FTLD. However, hippocampal sclerosis was more common in elderly patients with FTLD than patients with presenile-onset FTLD (82% vs 37%) and more severe in elderly patients with FTLD (P < .05). By contrast, severe atrophy of the frontal and temporal lobes was less common in elderly patients with FTLD (frontal: 45%; temporal: 27%) than patients with presenile-onset FTLD (frontal: 63%; temporal: 78%). Elderly patients with FTLD represented 3.2% of all elderly patients with dementia autopsied at Newcastle General Hospital. CONCLUSIONS Frontotemporal lobar degeneration in elderly patients does exist as a separate entity from presenile-onset FTLD. Its main features include (1) clinically frequent memory loss and behavioral change predominating over language and semantic dysfunction and (2) neuropathologically prominent hippocampal sclerosis but less pronounced cortical lobar atrophy. Clinically, FTLD in elderly patients is underrecognized and should be considered in the elderly subjects presenting with an “atypical Alzheimer disease” phenotype.

[1]  T. Griffiths,et al.  Frontotemporal lobar degeneration in a very young patient is associated with fused in sarcoma (FUS) pathological changes , 2012, Neuropathology and applied neurobiology.

[2]  D. Neary,et al.  Pathological correlates of frontotemporal lobar degeneration in the elderly , 2011, Acta Neuropathologica.

[3]  D. Dickson,et al.  Hippocampal Sclerosis in the Elderly: Genetic and Pathologic Findings, Some Mimicking Alzheimer Disease Clinically , 2011, Alzheimer disease and associated disorders.

[4]  C. Haass,et al.  TDP-43 and FUS: a nuclear affair , 2011, Trends in Neurosciences.

[5]  D. Dickson,et al.  Common Variant in GRN Is a Genetic Risk Factor for Hippocampal Sclerosis in the Elderly , 2010, Neurodegenerative Diseases.

[6]  John Q. Trojanowski,et al.  Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update , 2009, Acta Neuropathologica.

[7]  H. Kretzschmar,et al.  A new subtype of frontotemporal lobar degeneration with FUS pathology. , 2009, Brain : a journal of neurology.

[8]  I. Mackenzie,et al.  Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions. , 2008, Brain : a journal of neurology.

[9]  D. Dickson,et al.  Hippocampal sclerosis in tau-negative frontotemporal lobar degeneration , 2007, Neurobiology of Aging.

[10]  J. Schneider,et al.  Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration , 2007, Acta Neuropathologica.

[11]  D. Dickson,et al.  TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease , 2007, Annals of neurology.

[12]  R. Petersen,et al.  Neuropathologic Features of Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions With Progranulin Gene (PGRN) Mutations , 2007, Journal of neuropathology and experimental neurology.

[13]  D. Dickson,et al.  Hippocampal sclerosis dementia differs from hippocampal sclerosis in frontal lobe degeneration , 2006, Acta Neuropathologica.

[14]  Julie S. Snowden,et al.  Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype , 2006, Acta Neuropathologica.

[15]  S. Melquist,et al.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.

[16]  Holger Hummerich,et al.  Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia , 2005, Nature Genetics.

[17]  J. Hodges,et al.  Clinicopathological correlates in frontotemporal dementia , 2004, Annals of neurology.

[18]  F. Pasquier,et al.  Natural History of Frontotemporal Dementia: Comparison with Alzheimer’s Disease , 2004, Dementia and Geriatric Cognitive Disorders.

[19]  Manabu Ikeda,et al.  Epidemiology of Frontotemporal Lobar Degeneration , 2004, Dementia and Geriatric Cognitive Disorders.

[20]  Keith A. Johnson,et al.  Neuropathology of Cognitively Normal Elderly , 2003, Journal of neuropathology and experimental neurology.

[21]  M. Sjögren,et al.  The prevalence of frontal variant frontotemporal dementia and the frontal lobe syndrome in a population based sample of 85 year olds , 2003, Journal of neurology, neurosurgery, and psychiatry.

[22]  R. Martins,et al.  Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia. , 2003, Brain : a journal of neurology.

[23]  J. Hodges,et al.  Staging disease severity in pathologically confirmed cases of frontotemporal dementia , 2003, Neurology.

[24]  R. Perry,et al.  Non-Picks frontotemporal dementia imitating schizophrenia in a 22-year-old man , 2003, Journal of Neurology.

[25]  A. Kertesz,et al.  The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia , 2000, Journal of the International Neuropsychological Society.

[26]  T D Bird,et al.  Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions , 2000, Neurology.

[27]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[28]  I Litvan,et al.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy. , 1999, Human molecular genetics.

[29]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[30]  Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[31]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[32]  Robert H. Perry,et al.  Senile dementia of Lewy body type A clinically and neuropathologically distinct form of Lewy body dementia in the elderly , 1990, Journal of the Neurological Sciences.

[33]  G. Blessed,et al.  Correlation between the 37-Item Mental Test Score and Abbreviated 10-Item Mental Test Score by Psychogeriatric Day Patients , 1987, British Journal of Psychiatry.

[34]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[35]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[36]  P. Davies,et al.  Hippocampal sclerosis: a common pathological feature of dementia in very old (≥80 years of age) humans , 2004, Acta Neuropathologica.

[37]  D. Geschwind,et al.  Epidemiology and genetics of frontotemporal dementia/Pick's disease , 2003, Annals of neurology.

[38]  J. Trojanowski,et al.  Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.

[39]  K. Jellinger,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. , 1996, Neurology.